Allogene Therapeutics' (ALLO) CEO David Chang on Q3 2020 Results - Earnings Call Transcript

Allogene Therapeutics' (ALLO) CEO David Chang on Q3 2020 Results - Earnings Call Transcript

SeekingAlpha

Published

Full Article